| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 156.54B | 162.25B | 154.92B | 138.25B | 127.82B | 120.64B |
| Gross Profit | 15.06B | 34.13B | 13.74B | 10.48B | 9.23B | 8.39B |
| EBITDA | 29.82B | 11.89B | 29.38B | 33.51B | 26.56B | 25.93B |
| Net Income | 6.86B | 7.65B | 6.66B | 12.25B | 5.92B | 5.65B |
Balance Sheet | ||||||
| Total Assets | 208.46B | 211.60B | 205.37B | 202.61B | 171.89B | 168.51B |
| Cash, Cash Equivalents and Short-Term Investments | 8.03B | 10.64B | 9.16B | 8.37B | 10.15B | 11.04B |
| Total Debt | 109.81B | 39.63B | 108.81B | 107.56B | 96.44B | 97.05B |
| Total Liabilities | 141.90B | 139.45B | 139.97B | 141.60B | 123.51B | 124.83B |
| Stockholders Equity | 65.99B | 71.54B | 64.82B | 60.46B | 48.38B | 43.67B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 4.42B | 1.78B | 3.63B | 909.00M | 2.60B |
| Operating Cash Flow | 0.00 | 9.45B | 4.02B | 5.27B | 2.72B | 5.09B |
| Investing Cash Flow | 0.00 | -4.45B | -2.07B | -16.54B | -1.86B | -4.67B |
| Financing Cash Flow | 0.00 | -3.69B | -1.33B | 9.64B | -1.78B | -1.54B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥119.62B | 9.20 | ― | 2.85% | 5.08% | -5.14% | |
76 Outperform | ¥14.45B | 7.37 | ― | 3.03% | 8.91% | 24.33% | |
72 Outperform | ¥50.62B | 7.13 | ― | 3.57% | 4.73% | 15.55% | |
72 Outperform | ¥1.06T | 10.73 | ― | 3.37% | 3.13% | 48.43% | |
64 Neutral | ¥392.57B | 11.14 | ― | 3.62% | 17.52% | -27.48% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
58 Neutral | ¥40.39B | 6.79 | ― | 3.90% | 53.30% | 35.91% |